J. B. Chemicals & Pharmaceuticals Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Nikhil Chopra
Chief executive officer
₹65.4m
Total compensation
| CEO salary percentage | 56.4% |
| CEO tenure | 3.3yrs |
| CEO ownership | n/a |
| Management average tenure | 1.3yrs |
| Board average tenure | 3.6yrs |
Recent management updates
Recent updates
J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM) Not Flying Under The Radar
Apr 19
J. B. Chemicals & Pharmaceuticals Limited Just Missed Earnings - But Analysts Have Updated Their Models
Feb 09J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM) Not Flying Under The Radar
Dec 22We Think J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Can Stay On Top Of Its Debt
Nov 29J. B. Chemicals & Pharmaceuticals' (NSE:JBCHEPHARM) Dividend Will Be Increased To ₹9.25
Aug 03J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Is Due To Pay A Dividend Of ₹8.50
Feb 11Is J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Using Too Much Debt?
Dec 03A Look At The Intrinsic Value Of J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM)
Sep 21J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Seems To Use Debt Quite Sensibly
Aug 03Estimating The Fair Value Of J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM)
Jun 15Does J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Have A Healthy Balance Sheet?
Mar 29J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Has Re-Affirmed Its Dividend Of ₹8.50
Feb 16With EPS Growth And More, J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Is Interesting
Jan 27J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Could Easily Take On More Debt
Nov 30Here's Why I Think J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Might Deserve Your Attention Today
Sep 24Are J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM) Investors Paying Above The Intrinsic Value?
Aug 03Do J. B. Chemicals & Pharmaceuticals's (NSE:JBCHEPHARM) Earnings Warrant Your Attention?
Jun 14How Does J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM) Fare As A Dividend Stock?
May 04Do J. B. Chemicals & Pharmaceuticals's (NSE:JBCHEPHARM) Earnings Warrant Your Attention?
Mar 13This Insider Has Just Sold Shares In J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM)
Feb 28CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | ₹5b |
| Sep 30 2023 | n/a | n/a | ₹5b |
| Jun 30 2023 | n/a | n/a | ₹4b |
| Mar 31 2023 | ₹65m | ₹37m | ₹4b |
| Dec 31 2022 | n/a | n/a | ₹4b |
| Sep 30 2022 | n/a | n/a | ₹4b |
| Jun 30 2022 | n/a | n/a | ₹4b |
| Mar 31 2022 | ₹59m | ₹18m | ₹4b |
| Dec 31 2021 | n/a | n/a | ₹4b |
| Sep 30 2021 | n/a | n/a | ₹5b |
| Jun 30 2021 | n/a | n/a | ₹4b |
| Mar 31 2021 | ₹32m | ₹7m | ₹4b |
Compensation vs Market: Nikhil's total compensation ($USD785.18K) is above average for companies of similar size in the Indian market ($USD552.42K).
Compensation vs Earnings: Nikhil's compensation has been consistent with company performance over the past year.
CEO
Nikhil Chopra
3.3yrs
Tenure
₹65,448,000
Compensation
Mr. Nikhil Ashokkumar Chopra serves as Chief Executive Officer and Whole-Time Director at J. B. Chemicals & Pharmaceuticals Limited since December 23, 2020 and has been its Director since May 10, 2020. He...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Whole-Time Director | 3.3yrs | ₹65.45m | no data | |
| President of Operations | no data | ₹23.54m | no data | |
| Vice President of HR & Administration | 8.3yrs | ₹11.55m | 0.00032% ₹ 925.7k | |
| Executive Vice President of Investor Relations | 1.3yrs | ₹14.33m | no data | |
| Vice President of Legal | 1.2yrs | ₹1.63m | no data | |
| President of Global Business | no data | ₹38.85m | 0.0052% ₹ 14.9m | |
| Executive Vice President of Operations of Daman | less than a year | ₹15.54m | 0.0064% ₹ 18.6m | |
| Executive Vice President of Supply Chain Operations | 1.3yrs | ₹17.60m | no data | |
| President of India Business | no data | ₹23.86m | no data | |
| President of R&D | no data | ₹12.34m | no data | |
| Executive Vice President of Operations for Ankleshwar & Panoli | 1.3yrs | ₹15.86m | no data | |
| Assistant Vice President | no data | ₹11.09m | 0.00093% ₹ 2.7m |
1.3yrs
Average Tenure
46yo
Average Age
Experienced Management: JBCHEPHARM's management team is not considered experienced ( 1.3 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Whole-Time Director | 3.5yrs | ₹65.45m | no data | |
| Chairman of Biotech Laboratories (Pty ) Ltd | no data | no data | no data | |
| Non-Executive & Independent Director | 3.7yrs | ₹7.50m | no data | |
| Non-Executive Director | 3.7yrs | no data | no data | |
| Non-Executive & Non-Independent Director | less than a year | no data | no data | |
| Non-Executive Director | 3.2yrs | no data | no data | |
| Non-Executive & Independent Director | 3.7yrs | ₹7.50m | no data |
3.6yrs
Average Tenure
63.5yo
Average Age
Experienced Board: JBCHEPHARM's board of directors are considered experienced (3.6 years average tenure).